Playback speed
10 seconds
2021 Updates on 2L CML and Beyond: TKIs (Imatinib, Dasatinib/Nilotinib/Bosutinib Continuation, Ponatinib), Omacetaxine, Asciminib, HQP1351
By
UAB Hematology Review 2021
FEATURING
Omer Jamy
By
UAB Hematology Review 2021
FEATURING
Omer Jamy
197 views
March 18, 2021
Login to view comments.
Click here to Login